000			01939 a2200469 4500
005			20250516025733.0
264		0	_c20120207
008			201202s 0 0 eng d
022			_a1600-0714
024	7		_a10.1111/j.1600-0714.2011.01017.x _2doi
040			_aNLM _beng _cNLM
100	1		_aCraythorne, Emma
245	0	0	_aRituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. _h[electronic resource]
260			_bJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology _cSep 2011
300			_a616-20 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdjuvants, Immunologic _xtherapeutic use
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntigens, CD20
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMouth Diseases _xcomplications
650	0	4	_aPemphigus _xcomplications
650	0	4	_aRituximab
650	0	4	_aSeverity of Illness Index
650	0	4	_aSkin Diseases _xcomplications
650	0	4	_aTreatment Outcome
700	1		_adu Viver, Anthony
700	1		_aMufti, Ghulam J
700	1		_aWarnakulasuriya, Saman
773	0		_tJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology _gvol. 40 _gno. 8 _gp. 616-20
856	4	0	_uhttps://doi.org/10.1111/j.1600-0714.2011.01017.x _zAvailable from publisher's website
999			_c20657692 _d20657692